Tindall, A., M.C. Kissell, 2026. The role of peanuts and tree nuts in improving diet and sleep quality: A pilot study and literature review. 18(4):579. doi: 10.3390/nu18040579.
Background: Peanuts and tree nuts are nutrient-dense foods associated with improved diet quality and reduced chronic disease risk. Diet quality and sleep are interrelated, but the relationship between nut consumption and sleep quality remains understudied, particularly among young adults. Objective: This study examined peanut and tree nut consumption, diet quality, and sleep quality in undergraduate students. Existing clinical trials on nut intake and sleep outcomes in healthy adults were reviewed. Methods: A pilot study recruited 46 undergraduates to complete three 24 h dietary recalls and self-report sleep quality. Recall days were categorized as containing nuts or no nuts. Diet quality was assessed using the Healthy Eating Index-2020 (HEI). A literature search of PubMed identified human clinical trials testing nut intake with sleep-related outcomes. Results: Sixteen percent of the 139 recall days contained nuts. Mean HEI scores were greater on days that contained nuts (64.9 ± 2.3) versus nut-free days (45.4 ± 1.1; p < 0.0001). Scores for total fruit, whole fruit, total protein, sea and plant protein, sodium, and refined grains were greater on nut-containing days (p < 0.05 for all). Participants reported better sleep on days following nut consumption (p = 0.04). From the literature search, four randomized controlled trials (RCTs) were identified with results varying by nut type, dosage, timing, and participants. Conclusions: The positive association observed in this pilot study between nut intake and improved diet quality, along with a modest link to better sleep quality, suggests that incorporating nuts regularly into the diet may help enhance overall dietary habits and contribute to improved sleep. The present trials suggest nut intake may improve sleep quality, but significant heterogeneity highlights the need for RCTs with objective sleep outcomes.
Liu, M., M. Wang, X. Fu, X. He, M. Wang, Y. Su, G. Liu, F. Hu, M. Zhang, Y. Zhao, D. Hu, 2026. Nut consumption and risk of cardiovascular disease events and all-cause mortality: A systematic review and dose-response meta-analysis of prospective cohort studies. Arch Cardiovasc Dis. 119(3):216-232. doi: 10.1016/j.acvd.2025.08.010.
Background: Evidence for the effects of nut consumption on cardiovascular disease (CVD) events and all-cause mortality has been reported inconsistently. Aims: To assess the associations between nut consumption and CVD events and all-cause mortality. Methods: We searched the Web of Science, Embase and PubMed up until 24 October 2023. In order to compute relative risks (RRs) and 95% confidence intervals (CIs), random-effects models were employed. Restricted cubic splines were performed to explore potential linear or non-linear associations. Heterogeneity was assessed (Cochran Q statistic) and quantified (I2-statistic). NutriGrade assessed the certainty of the evidence. Results: Thirty-three publications (63 studies) were included. Comparisons between individuals with the highest versus lowest intake of nuts resulted in RRs (95% CIs) for coronary heart disease (CHD), stroke, CVD, CVD mortality and all-cause mortality of 0.81 (0.75-0.87), 0.91 (0.84-0.99), 0.86 (0.82-0.91), 0.74 (0.70-0.78) and 0.77 (0.73-0.81), respectively. With per 28-g increases in weekly nut intake, the RRs (95% CIs) for CHD, stroke, CVD, CVD mortality and all-cause mortality were 0.96 (0.95-0.97), 0.99 (0.97-1.01), 0.98 (0.97-0.99), 0.90 (0.86-0.94) and 0.92 (0.90-0.94), respectively. Nut intake was linearly associated with incidence of stroke (Pnon-linearity=0.691), CVD (Pnon-linearity=0.101) and CVD mortality (Pnon-linearity=0.069) and non-linearly associated with CHD (Pnon-linearity<0.05) and all-cause mortality (Pnon-linearity<0.001). Conclusions: This systematic review and meta-analysis revealed an association between nut consumption and reduced risk of CVD and all-cause mortality. It highlighted the importance of nuts as a dietary supplement in the primary prevention of CVD and all-cause mortality.
Metoudi, M., I. Sadler, S. Kassam, D. Aune, 2026. Nut consumption and the risk of hypertension: a systematic review and dose–response meta-analysis of prospective studies. BJN, page 1 of 8. doi: 10.1017/S0007114526108137.
Previous studies have suggested that a high intake of nuts may reduce the risk of hypertension; however, the available data have been limited. Several additional studies have recently been published on the topic. We therefore conducted a systematic review and meta-analysis of cohort studies on nut consumption and hypertension to provide an updated assessment of the evidence. PubMed and Embase databases were searched up to 4 April 2026 for prospective cohort studies with adjusted relative risk (RR) estimates published in English on the association between nut consumption and hypertension risk. Random-effects models were used to estimate summary RRs and 95% CIs. We used World Cancer Research Fund (WCRF) criteria to assess the strength of the evidence. Eight studies (20 665 cases, 143 380 participants) were included in the meta-analysis. The summary RR for the highest v. lowest category of nut intake was 0·84 (95% CI 0.77–0.91, I2=50%, Pheterogeneity = 0.05, n 8) and per 28 g/d was 0.80 (95 % CI 0.71 0.89, I2 = 75 %, Pheterogeneity < 0.0001, n 8). There was no indication of publication bias. There was some indication of non-linearity (Pnon-linearity = 0·07), and there was a 26% reduction in risk when comparing 30g/d v. 0g/d. Using WCRF criteria to assess the strength of evidence, we graded the likelihood of causality as probable. In this meta-analysis of prospective cohort studies, we found further evidence for a reduced risk of hypertension with higher intake of nuts. These findings support dietary guideline recommendations to include a serving of nuts per day.
Xu, J., K. Pu, W. Sun, C. Pang, D. Li, S. Zang, 2025. Association of nut consumption and sarcopenia in Chinese older adults. Sci Rep. 15, 17598. https://doi.org/10.1038/s41598-025-02389-x
Sarcopenia emerges as a predominant health concern among the older adults, it makes the identification of relational factors crucial. Nut, a universally consumed dietary component, is posited to confer benefits to the musculoskeletal system. This study aimed to elucidate the association between nut consumption and sarcopenia in Chinese older adults. Data concerning nut consumption and sarcopenia were sourced from the 2018 wave of the Chinese Longitudinal Healthy Longevity Survey (CLHLS). The analysis incorporated 14,281 participants furnishing valid responses. This research employed logistic regression to investigate the association between nut consumption and sarcopenia. A total of 14,181 older adults (mean age = 84.86 ± 11.47 years and 55.08% were female) were included in this study. This study found an inverse association between nut consumption and sarcopenia in Chinese older adults, with higher nut consumption associated with a lower prevalence of sarcopenia, even after controlling for confounders. Compared with the nut consumption group of occasionally/rarely or never, the adjusted ORs of sarcopenia for at least once per month, at least once per week, and almost every day were 0.78 (95% CI: 0.66, 0.91), 0.81 (95% CI: 0.69, 0.95), and 0.62 (95% CI: 0.51, 0.77), respectively. Moreover, the result also displayed there is a significant interaction of nut consumption with gender (P-value = 0.016). This study identified an inverse association between nut consumption and sarcopenia. Introducing nut into the dietary regimen might present an accessible approach to bolster musculoskeletal health among the older adults.